Tirzepatide dosing should follow FDA-approved protocols: initiate at 2.5 mg subcutaneously once weekly for four weeks, then increase to 5 mg weekly
Transparency and Labeling One of the strongest signals of trust is a clear label
These drugs are becoming increasingly accessible, and it is concerning that, in some cases, people can simply go online and order these kinds of medications when they may not have a full understanding of what could potentially happen
Heres a general breakdown of some common GLP-1 medications: Ozempic (semaglutide): Stays in your system for about 5-6 weeks after the last dose due to its long half-life of approximately 7 days per dose
When the FDA declared a semaglutide shortage in 2022, pharmacies, telehealth companies and other health care providers could manufacture copycat GLP-1 therapies
All models included participants' gender, ages, mothers' ages, fathers' ages, and races as covariates